Evidence map›Paper›PMID 23785004›Full record

ArticleCirculation2013

Gβγ-independent recruitment of G-protein coupled receptor kinase 2 drives tumor necrosis factor α-induced cardiac β-adrenergic receptor dysfunction.

Neelakantan T Vasudevan, Maradumane L Mohan, Manveen K Gupta, Elizabeth E Martelli, Afshan K Hussain, Yilu Qin, Unni M Chandrasekharan, David Young, Arthur M Feldman, Subha Sen and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Circulation, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 39 citations in OpenAlex.

  1. Trial
  2. Review
  3. The βAdvances in pharmacological and pharmaceutical sciences · 2024
    Review
  4. Article
  5. Article
  6. BRET-Based Biosensors to Measure Agonist Efficacies in Histamine HInternational journal of molecular sciences · 2022
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Carvedilol Prevents Redox Inactivation of Cardiomyocyte ΒJACC. Basic to translational science · 2018
    Article
  17. MyocardialJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2018
    Article
  18. Proinflammatory Cytokines Mediate GPCR Dysfunction.Journal of cardiovascular pharmacology · 2017
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Neelakantan T VasudevanDepartment of Molecular Cardiology, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, USA.
Maradumane L Mohan
Manveen K Gupta
Elizabeth E Martelli
Afshan K Hussain
Yilu Qin
Unni M Chandrasekharan
David Young
Arthur M Feldman
Subha Sen
Gerald W Dorn
Paul E Dicorleto
Sathyamangla V Naga Prasad
Temple University · US

Funding

Vascular Cell function and AtherosclerosisP01HL029582 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI FOX, PAUL L · 1985 to 2019
$32.0M
Targeted Cancer Therapeutics and Heart Failure: Mechanisms and Post-injury RepairP01HL091799 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI HOUSER, STEVEN R · 2008 to 2018
$23.1M
G-Protein Receptor Kinases in Cardiac Stress AdaptationR01HL087871 · NHLBI · WASHINGTON UNIVERSITY · PI DORN, GERALD W. · 2007 to 2016
$4.1M
Novel Regulation of Beta Andregenic Receptor FunctionR01HL089473 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI PRASAD, SATHYAMANGLA V · 2008 to 2017
$3.7M
INITIATION OF MYOCARDIAL HYPERTROPHY IN HYPERTENSIONR01HL047794 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI SEN, SUBHA · 1994 to 2008
$3.3M
NHLBI NIH HHS HL29582NHLBI NIH HHS HL47794NHLBI NIH HHS HL89473NHLBI NIH HHS HL89473-02S1NHLBI NIH HHS P01 HL029582NHLBI NIH HHS P01 HL091799NHLBI NIH HHS R01 HL047794NHLBI NIH HHS R01 HL087871NHLBI NIH HHS R01 HL089473
6 · The paper itself

Abstract

backgroundProinflammatory cytokine tumor necrosis factor-α (TNFα) induces β-adrenergic receptor (βAR) desensitization, but mechanisms proximal to the receptor in contributing to cardiac dysfunction are not known. METHODS AND

resultsTwo different proinflammatory transgenic mouse models with cardiac overexpression of myotrophin (a prohypertrophic molecule) or TNFα showed that TNFα alone is sufficient to mediate βAR desensitization as measured by cardiac adenylyl cyclase activity. M-mode echocardiography in these mouse models showed cardiac dysfunction paralleling βAR desensitization independent of sympathetic overdrive. TNFα-mediated βAR desensitization that precedes cardiac dysfunction is associated with selective upregulation of G-protein coupled receptor kinase 2 (GRK2) in both mouse models. In vitro studies in β2AR-overexpressing human embryonic kidney 293 cells showed significant βAR desensitization, GRK2 upregulation, and recruitment to the βAR complex following TNFα. Interestingly, inhibition of phosphoinositide 3-kinase abolished GRK2-mediated βAR phosphorylation and GRK2 recruitment on TNFα. Furthermore, TNFα-mediated βAR phosphorylation was not blocked with βAR antagonist propranolol. Additionally, TNFα administration in transgenic mice with cardiac overexpression of Gβγ-sequestering peptide βARK-ct could not prevent βAR desensitization or cardiac dysfunction showing that GRK2 recruitment to the βAR is Gβγ independent. Small interfering RNA knockdown of GRK2 resulted in the loss of TNFα-mediated βAR phosphorylation. Consistently, cardiomyocytes from mice with cardiac-specific GRK2 ablation normalized the TNFα-mediated loss in contractility, showing that TNFα-induced βAR desensitization is GRK2 dependent.

conclusionsTNFα-induced βAR desensitization is mediated by GRK2 and is independent of Gβγ, uncovering a hitherto unknown cross-talk between TNFα and βAR function, providing the underpinnings of inflammation-mediated cardiac dysfunction.

Indexed as

Adrenergic beta-AntagonistsAnimalsDisease Models, AnimalG-Protein-Coupled Receptor Kinase 2Heart FailureHEK293 CellsHumansIntercellular Signaling Peptides and ProteinsMiceMice, TransgenicMyocardial ContractionMyocytes, CardiacPhosphatidylinositol 3-KinasesPhosphorylationPropranololReceptors, Adrenergic, betaAdrenergic beta-AntagonistsG-Protein-Coupled Receptor Kinase 2GRK2 protein, mouseIntercellular Signaling Peptides and ProteinsmyotrophinPhosphatidylinositol 3-KinasesPropranololReceptors, Adrenergic, betaReceptors, Tumor Necrosis Factor, Type IITumor Necrosis Factor-alphaG-protein coupled receptor kinase 2heart failureinflammationphosphoinositide 3-kinasetumor necrosis factor-αtumor necrosis factor-α receptor 2β-adrenergic receptor

Identifiers

PMID23785004
PMCPMC3874808
OpenAlexW2067772003

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.